Clinical trial · Observational
Improving Symptom Self-management in Adolescents & Young Adults With Cancer
NCT02974569CI-TRIAL-00030890CSCAT2completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluates the use of the Computerized Symptom Capture Tool (C-SCAT), which creates an image of the symptoms the participant is experiencing, for improving symptom self-management in adolescents and young adults with cancer. In this one-group trial, participants will complete the C-SCAT and use it during two clinic visits with their oncology providers.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Symptom Clusters | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Computer Symptom Capture Tool | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- C-SCAT
- description
- C-SCAT arm: Completes and uses Computerized Symptom Capture Tool (C-SCAT) during visit with provider for two clinic visits.
- interventionNames
- Device: Computer Symptom Capture Tool
Primary outcomes (5)
- measure
- Change in self-efficacy of symptom management measured by PROMIS Self-efficacy of symptom management scale.
- timeFrame
- Baseline, immediately after first provider visit (approx. 2 -4 weeks from baseline) and then immediately after second provider visit (approx. 6-8 weeks from baseline)
- measure
- Change in patient-provider communication from patient perspective measured by Patient-Provider Communication Scale.
- timeFrame
- Baseline, immediately after first provider visit (approx. 2 -4 weeks from baseline) and then immediately after second provider visit (approx. 6-8 weeks from baseline)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
- Maximum age
- 29 Years
Show eligibility criteria text
Inclusion Criteria: * 15 to 29 years of age with a diagnosis of cancer (primary, relapsed/recurrent, refractory, progressive, or secondary malignancy) receiving myelosuppressive chemotherapy. * Completion of at least one cycle of therapy for cancer and anticipated to have at least two additional cycles of myelosuppressive chemotherapy as part of the treatment plan. * Ability to speak and understand English as required to complete the C-SCAT and study measures. * Ability to use a tablet computer. Exclusion Criteria: * Cognitive and/or physical inabilities to complete the proposed study measures as determined by self--report, parent report of minor, or medical chart.
References
Publications (0)
Data not yet available
No reference posted for this study.